Achieve Life Sciences
ACHV
11 hedge funds and large institutions have $1.78M invested in Achieve Life Sciences in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 12 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
9.33% more ownership
Funds ownership: 12.53% → 21.86% (+9.3%)
5% less capital invested
Capital invested by funds: $1.86M → $1.78M (-$87.2K)
52% less funds holding
Funds holding: 23 → 11 (-12)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$845K |
| 2 |
SCM
Sio Capital Management
New York
|
+$814K |
| 3 |
Renaissance Technologies
New York
|
+$160K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$109K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$189 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$93K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$84K |
| 3 |
VF
Virtu Financial
New York
|
-$82K |
| 4 |
Walleye Trading
New York
|
-$68K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$46K |
ACHV Hedge Fund Activity: Q4 2018 in Review
11 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2018, worth a combined $1.78M — down 4.7% from $1.86M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ACHV and 1 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $845K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $93K sold.
- 11 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2018, down from 23 in Q3 2018.
- Funds reported $1.78M of Achieve Life Sciences stock for Q4 2018, down 4.7% quarter-over-quarter.
- 1 fund opened new Achieve Life Sciences positions in Q4 2018 and 12 closed out, a net change of -11 holders.
- The largest Achieve Life Sciences buyer in Q4 2018 was Armistice Capital, an estimated $845K added.
- The largest Achieve Life Sciences seller in Q4 2018 was Susquehanna International Group, an estimated $93K sold.
Based on aggregated 13F filings for Q4 2018.